Comparative Effectiveness of Behavioral or Drug Therapy for Overactive Bladder Symptoms in Parkinson Disease
Objective: Assess the comparative effectiveness of behavioral or solifenacin drug therapy over 12 weeks for overactive bladder (OAB) symptoms according to the International Consultation on…Nocturnal Polyuria in Parkinson’s Disease
Objective: To characterise the prevalence of nocturnal polyuria in a cohort of people with Parkinson’s disease (PD) with lower urinary tract symptoms. Background: Lower urinary…Urinary Symptoms and Parkinson’s Disease: The Patient’s Perspective
Objective: To learn about prevalence rates and the impact of urinary symptoms on day-to-day function and quality of life from the patient’s perspective. Background: Urinary…Safinamide in the treatment of URINARY symptoms in PARKinson’s disease (SURINPARK)
Objective: We compared the effects of safinamide on the urinary symptoms of Parkinson's disease with other therapies. Background: Urinary symptoms (US) are common, disabling and…The frequency of lower urinary tract symptoms in patients with Parkinson’s disease and Clinical efficacy of istradefylline
Objective: We evaluated using the questionnaire to investigate the frequency of lower urinary tract symptoms (LUTSs) in Parkinson's disease at our clinic. For patients with…Single-centre open label exploratory phase IIb pilot study of exogenous oral Melatonin for the treatment of Nocturia in adults with Parkinson’s disease
Objective: To evaluate the effect of melatonin on nocturia. Background: Nocturia is one of the commonest non motor symptoms in Parkinsons’ disease (PD), and has…Effect of Urinary Dysfunction on Fatigue Syndrome in Parkinson’s disease
Objective: to investigate the relationship between urinary dysfunction and fatigue syndrome in Parkinson`s disease Background: Fatigue syndrome (FS) is an overwhelming sense of tiredness, lack…Abnormal melatonin secretion rhythm and nocturnal polyuria in patients with Parkinson’s disease
Objective: To evaluate the association between melatonin secretion rhythm and nocturnal polyuria, and the pathophysiology of nocturnal polyuria in PD. Background: Patients with PD have…Neurogenic bladder in progressive supranuclear palsy: A comparison with Parkinson’s disease and multiple system atrophy
Objective: To compare the features of urinary dysfunction in Progressive supranuclear palsy (PSP) with those of idiopathic Parkinson’s disease (IPD) and multiple system atrophy (MSA). Background:…Preliminary Report on the MAESTRO Study: A Pilot Study of Mirabegron and Behavioral Modification including Pelvic Floor Exercise for Overactive Bladder in Parkinson Disease.
Objective: To report enrollment and tolerability data of mirabegron treatment in PD patients with OAB. Background: Lower urinary tract symptoms in PD have an estimated…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.